Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on November 3, 2026

Nov. 3, 2026

Geron Corporation to Participate in the Stifel 2026 Healthcare Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

CalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations

Indeterminate GlobeNewswire

Nov. 3, 2026

Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation

Indeterminate GlobeNewswire

Nov. 3, 2026

Conavi Medical Presents Data Demonstrating Feasibility of Saline-Based Hybrid IVUS–OCT Imaging with OCTIV™ at TCT 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Beta Bionics Announces Participation at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in London

Indeterminate GlobeNewswire

Nov. 3, 2026

ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific

Indeterminate GlobeNewswire

Nov. 3, 2026

Palvella Therapeutics to Participate in the Stifel 2026 Healthcare Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Decoy Therapeutics Provides Third Quarter 2026 Business Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Kailera Therapeutics to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 3, 2026

MagicBody Details Four Programs Held Monthly: Training That Continues After Pilates Instructor Certification

Indeterminate EIN Presswire

Nov. 3, 2026

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

Indeterminate GlobeNewswire

Nov. 3, 2026

Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities

Indeterminate GlobeNewswire

Nov. 3, 2026

Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion

Indeterminate GlobeNewswire

Nov. 3, 2026

Cardiff Oncology to Participate in the UBS Global Biopharma Conference

Indeterminate GlobeNewswire